TRACY RIDDLE: Open Payments
NPI 1083890271 · BELLEVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 17 payments from 10 companies in 2025. Trend: 2023 $58 · 2024 $227 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| ABBVIE INC. | 2 | $42 |
| Novo Nordisk Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Lilly USA, LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $19 |
| Amgen Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, Ozempic, Veozah, BREZTRI, Wegovy, FARXIGA.
Industry payments across FL — which companies pay providers there.
